Clinical Trials in Atlanta

Showing 2721-2740 of 19,805 trials

TVMR With the INNOVALVE System Trial - Early Feasibility Study

NCT04919980

Study to evaluate the safety and performance of the INNOVALVE system

Mitral Valve Regurgitation (Degenerative or Functional)

Edwards Lifesciences65 participantsStarted Sep 2022

Los Angeles, California, United States • Naples, Florida, United States • Atlanta, Georgia, United States +14 more locations

COMPLETEDPhase 2< 1 mile

Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy

NCT05834738

The ASSIST study is a phase 2, double-blind, placebo-controlled crossover study to evaluate the safety and efficacy of atrasentan vs. placebo in subjects with IgA nephropathy (IgAN) while on background standard of care therapy and an SGLT2 inhibitor (SGLT2i).

IgA NephropathyImmunoglobulin A Nephropathy

Novartis Pharmaceuticals54 participantsStarted Jul 2023

Birmingham, Alabama, United States • Atlanta, Georgia, United States • Oak Brook, Illinois, United States +27 more locations

TVMR With the INNOVALVE System Trial - Early Feasibility Study

Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy

Find Trials by Condition in Atlanta

Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis

Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)

Mental Stress Reactivity in Women With CMD

A Study of HMPL-306 in Advanced Hematological Malignancies With mIDH

Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer

Pivotal Study of the Velocity™ pAVF System

A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma

A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer

A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study

A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial

Safety and Immunogenicity Study of Self-Amplifying RNA Pandemic Influenza Vaccine in Adults

Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery

A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.